NVS Stock Summary and Trading Ideas (Novartis Ag | NYSE:NVS)

Novartis develops and manufactures innovative drugs. Key areas of drug development are oncology, immunology, neuroscience, and cardiovascular, renal, and metabolic. It also has an established medicines business, which includes off-patent franchises. The company sells its products globally, with the United States constituting close to one-third of total revenue.

Novartis Ag trades on the NYSE stock market under the symbol NVS.

As of August 25, 2026, NVS stock price climbed to $159.98 with 899,915 million shares trading.

NVS has a beta of 0.03, meaning it tends to be less sensitive to market movements. NVS has a correlation of 0.00 to the broad based SPY ETF.

NVS has a market cap of $304.08 billion. This is considered a Mega Cap stock.

Last quarter Novartis Ag reported $14 billion in Revenue and $2.41 earnings per share. This beat revenue expectation by $284 million and exceeded earnings estimates by $.25.

In the last 3 years, NVS traded as high as $170.46 and as low as $92.19.

The top ETF exchange traded funds that NVS belongs to (by Net Assets): DFIV, DFAI, DFIC, PPH, AVDE.

NVS has outperformed the market in the last year with a price return of +29.7% while the SPY ETF gained +19.9%. NVS has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +5.2% and +2.0%, respectively, while the SPY returned +3.0% and -0.9%, respectively.

NVS support price is $155.79 and resistance is $160.25 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that NVS shares will trade within this expected range on the day.